Oritavancin

CAS: 171099-57-3

Ref. 3D-AA16180

Produktinformation

• Name: Oritavancin
• Synonyme: (4R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-a-L-arabinohexopyranosyl)-N3-(p-(p-chlorophenyl)benzyl)vancomycin, (4''R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-N3''-(4'-chloro[1,1'-biphenyl]-4-ylmethyl)vancomycin, Ly-333328, Orbactiv, Vancomycin, 22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-α-<span class="text-smallcaps">L</span>-arabino-hexopyranosyl)-N^3′′-[(4′-chloro[1,1′-biphenyl]-4-yl)methyl]-, (4′′R)-, Vancomycin, 22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-α-L-arabino-hexopyranosyl)-N3′′-[(4′-chloro[1,1′-biphenyl]-4-yl)methyl]-, (4′′R)-

Beschreibung

Oritavancin is a semi-synthetic lipoglycopeptide antibiotic that inhibits bacterial cell wall synthesis by binding to the D-alanyl-D-alanine moiety of peptidoglycan precursors. It has been shown to be active against methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium perfringens. Oritavancin also inhibits the growth of thp-1 cells in vitro and has been shown to be effective against endocarditis caused by MRSA.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 1,793.1 g/mol
• Formel: C₈₆H₉₇Cl₃N₁₀O₂₆
• Reinheit: Min. 95%
• Farbe/Form: Powder